Interferon alfa therapy for age‐related macular degeneration
Referencias
Additional references
Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New England Journal of Medicine 1994;331(22):1480‐7.
Alderson P, Green S, Higgins JPT, editors. Cochrane Reviewers’ Handbook 4.2.2 [updated March 2004]. The Cochrane Library, Issue 1, 2004. Chichester: John Wiley & Sons, Ltd, 2004.
Age‐Related Eye Disease Study Research Group. Risk factors associated with age‐related macular degeneration A case‐control study in the age‐related eye disease study: age‐related eye disease study report number 3. Ophthalmology 2000;107(12):2224‐32.
Age‐Related Eye Disease Study Research Group. A randomized, placebo‐controlled, clinical trial of high‐dose supplementation with vitamins C and E, beta carotene, and zinc for age‐related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology 2001;119(10):1414‐36.
Baron S, Tyring SK, Fleischmann WR, Coppenhaver DH, Niesel DW, Klimpel GR, et al. The interferons. Mechanisms of action and clinical applications. JAMA 1991;266(10):1375‐83.
Brouty‐Boye D, Zetter BR. Inhibition of cell motility by interferon. Science 1980;208(4443):516‐8.
Chumbley LC. Impressions of eye diseases among Rhodesian blacks in Mashonaland. South African Medical Journal 1977;52(8):316‐8.
The Eye Disease Case‐Control Study Group. Risk factors for neovascular age‐related macular degeneration. Archives Ophthalmology 1992;110(12):1701‐8.
Ghafour IM, Allan D, Foulds WS. Common causes of blindness and visual handicap in the west of Scotland. British Journal Ophthalmology 1983;67(4):209‐13.
Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO. Factors associated with age‐related macular degeneration An analysis of data from the first National Health and Nutrition Examination Survey. American Journal of Epidemiology 1988;128(4):700‐10.
Gregor Z, Joffe L. Senile macular changes in the black African. British Journal Ophthalmology 1978;62(8):547‐50.
Hyman LG, Lilienfeld AM, Ferris FL, Fine SL. Senile macular degeneration: a case‐control study. American Journal of Epidemiology 1983;118(2):213‐27.
Hyman L. Epidemiology of eye disease in the elderly. Eye 1987;1(Pt 2):330‐41.
Klein R, Klein BE, Jensen SC, Moss SE, Cruickshanks KJ. The relation of socioeconomic factors to age‐related cataract, maculopathy, and impaired vision The Beaver Dam Eye Study. Ophthalmology 1994;101(12):1969‐79.
Klein R, Rowland ML, Harris MI. Racial/ethnic differences in age‐related maculopathy Third National Health and Nutrition Examination Survey. Ophthalmology 1995;102(3):371‐81.
Klein R. The Beaver Dam Eye Study: the relation of age‐related maculopathy to smoking. Archives of Ophthalmology 1996;114:1518‐23.
Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten‐year incidence and progression of age‐related maculopathy: The Beaver Dam eye study. Ophthalmology 2002;109(10):1767‐79.
Kvanta A Algvere PV, Berglin L, Seregard S. Subfoveal fibrovascular membranes in age‐related macular degeneration express vascular endothelial growth factor. Investigative Ophthalmology & Visual Science 1996;37(9):1929‐34.
Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, et al. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973‐1975. Survey of Ophthalmology 1980;24(Suppl):335‐610.
Lopez PF, Sippy BD, Lambert HM, Thach AB, Hinton DR. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age‐related macular degeneration‐related choroidal neovascular membranes. Investigative Ophthalmology & Visual Science 1996;37(5):855‐68.
Miller JW, Stinson WG, Folkman J. Regression of experimental iris neovascularization with systemic alpha‐interferon. Ophthalmology 1993;100(1):9‐14.
Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age‐related maculopathy in Australia The Blue Mountains Eye Study. Ophthalmology 1995;102(10):1450‐60.
Mitchell P, Wang JJ, Smith W, Leeder SR. Smoking and the 5‐year incidence of age‐related maculopathy: the Blue Mountains Eye Study. Archives Ophthalmology 2002;120(10):1357‐63.
Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy Five‐year results from randomized clinical trials. Archives Ophthalmology 1991;109(8):1109‐14.
O'Shea JG. Age‐related macular degeneration. Postgraduate Medical Journal 1998;74(870):203‐7.
Paetkau ME, Boyd TA, Grace M, Bach Mills J, Winship B. Senile disciform macular degeneration and smoking. Canadian Journal of Ophthalmology 1978;13(2):67‐71.
Piguet B, Wells JA, Palmvang IB, Wormald R, Chisholm IH, Bird AC. Age‐related Bruch's membrane change: a clinical study of the relative role of heredity and environment. British Journal of Ophthalmology 1993;77(7):400‐3.
Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant age‐related maculopathy in men. Archives Ophthalmology 2001;119(9):1259‐65.
Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age‐related maculopathy. American Journal Ophthalmology 1997;123(2):199‐206.
Silvestri G, Johnston PB, Hughes AE. Is genetic predisposition an important risk factor in age‐related macular degeneration?. Eye 1994;8(Pt 5):564‐8.
Treatment of Age‐related macular degeneration with Photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age‐related macular degeneration with verteporfin: one‐year results of 2 randomized clinical trials‐‐TAP report. Archives Ophthalmology 1999;117(10):1329‐45.
Tielsch J A. Vision problems in the US: a report on blindness and vision impairment in adults age 40 and older. Prevent Blindness America. Illinois: Schaumberg, 1994.
Ting TD, Oh M, Cox TA, Meyer CH, Toth CA. Decreased visual acuity associated with cystoid macular edema in neovascular age‐related macular degeneration. Archives Ophthalmology 2002;120(6):731‐7.
Van Kerckhoven W, Lafaut B, Follens I, De Laey JJ. Features of age‐related macular degeneration on optical coherence tomography. Bulletin de la Societe Belge d'Ophtalmologie 2001;281:75‐8.
Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, de Jong PT. The prevalence of age‐related maculopathy in the Rotterdam Study. Ophthalmology 1995;102(2):205‐10.
Wormald R, Evans J, Smeeth L, Henshaw K. Photodynamic therapy for nonvascular age‐related macular degeneration. The Cochrane Database of Systematic Reviews 2003. Art. No.: CD002030. DOI: 10.1002/14651858.CD002030, Issue 2.
